us.eisai.com

Eisai is a global pharmaceutical company founded in 1992, dedicated to its human health care (hhc) mission, which serves as the core of its business philosophy and drives innovation. The company operates within the Healthcare and Pharmaceuticals industries, focusing on understanding patient needs to develop groundbreaking treatments. With a singular focus on its mission, Eisai emphasizes the importance of direct patient interaction as the source of its research and development breakthroughs. The company's commitment extends to fostering a culture where employees worldwide share this common value, aiming to contribute significantly to patients' well-being and quality of life.

Operating with a substantial workforce of 1,000 to 5,000 employees, Eisai maintains a significant presence, though its location count is noted as one. This concentrated operational structure supports its global mission. The company's dedication to its people and its mission is a key aspect of its operational strategy, aiming to translate deep patient understanding into tangible therapeutic advancements. For insights into the people driving this mission, one can explore Meet Eisai's team. This focus on human capital is integral to achieving its ambitious healthcare goals and delivering innovative solutions to patients worldwide.

Eisai generated a revenue of $675.1M, reflecting its market position within the competitive pharmaceutical landscape. The company competes with numerous entities in the healthcare sector, including NeueHealth, Transcarent, and Cencora, among others. Its strategic focus on patient-centric innovation and its established hhc philosophy position it as a dedicated player in advancing medical treatments and improving patient outcomes. The company's long-standing presence since 1992View more...